3 withdrawn. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Osteopenia: new trials by email Literature Review of Osteopenia trials Research Report on Osteopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Reducing Nucleotide Exposure on Bone Health (ReNew) Dolutegravir (DTG) 50MG/lamivudine (3TC) 300MG FIXED DOSE COMBINATION (FDC), Current tenofovir alafenamide (TAF)-containing ART regimen - HIV/AIDS, HIV-1-infection | Phase 2 | Withdrawn | Philip Grant | 2019-08-01 | 2021-03-15 | |
| Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D Placebo, Vitamin D3 - Primary Hyperparathyroidism, Hypercalcemia | Phase 2 / Phase 3 | Withdrawn | Columbia University | 2010-05-01 | 2015-03-05 | |
| Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD Teriparatide, Teriparatide Nasal Spray - Osteopenia, Osteoporosis | Phase 2 | Withdrawn | Nastech Pharmaceutical Company, Inc. | 350 | 2008-03-01 | 2008-03-13 |
Bone Diseases, Metabolic (3) · Osteoporosis (2) · Acquired Immunodeficiency Syndrome (1) · Hypercalcemia (1) · Hyperparathyroidism, Primary (1) · Vitamin D Deficiency (1)
Bone Diseases (3) · Metabolic Diseases (3) · Musculoskeletal Diseases (3) · Nutritional and Metabolic Diseases (3) · Avitaminosis (1) · Blood-Borne Infections (1) · Calcium Metabolism Disorders (1) · Communicable Diseases (1) · Deficiency Diseases (1) · Endocrine System Diseases (1) · Genital Diseases (1) · HIV Infections (1) · Hyperparathyroidism (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1)
Cholecalciferol (1) · Lamivudine (1) · Teriparatide (1) · dolutegravir (1)
Columbia University (1) · Nastech Pharmaceutical Company, Inc. (1) · Philip Grant (1)
United States (2)
Gordon Brandt, MD (1) · Philip Grant, MD (1) · Shonni J. Silverberg, MD (1)
R01DK084986 (1)